The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Advanced hepatocellular carcinoma (HCC) treated with sunitinib (Su) and transarterial chemoembolization (TACE): Phase II trial final report.
Renuka V. Iyer
Research Funding - Renuka Iyer
Garin Tomaszewski
No relevant relationships to disclose
Yuhsin V Wu
No relevant relationships to disclose
Boris W. Kuvshinoff
No relevant relationships to disclose
Adrienne E. Groman
No relevant relationships to disclose
Nikhil I. Khushalani
No relevant relationships to disclose
Catherine Grande
No relevant relationships to disclose
Patricia D. Zagst
No relevant relationships to disclose
Kimberly Clark
No relevant relationships to disclose
Gerald J. Fetterly
No relevant relationships to disclose